E. Ok, G. Asci, S. Bayraktaroglu, H. Toz, M. Ozkahya et al., Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis, J Am Soc Nephrol, vol.27, issue.8, pp.2475-86, 2016.

K. Yamada, S. Fujimoto, R. Nishiura, H. Komatsu, M. Tatsumoto et al., Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis, Nephrol Dial Transplant, vol.22, issue.7, pp.2032-2039, 2007.

W. G. Goodman, J. Goldin, B. D. Kuizon, C. Yoon, B. Gales et al., Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, vol.342, issue.20, pp.1478-83, 2000.

G. M. London, C. Marty, S. J. Marchais, A. P. Guerin, F. Metivier et al., Arterial calcifications and bone histomorphometry in end-stage renal disease, J Am Soc Nephrol, vol.15, issue.7, pp.1943-51, 2004.

G. A. Block, D. M. Spiegel, J. Ehrlich, R. Mehta, J. Lindbergh et al., Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis, Kidney Int, vol.68, issue.4, p.16164659, 2005.

, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J KidneyDis, vol.42, pp.1-201, 2003.

D. J. Goldsmith, A. Covic, D. Fouque, F. Locatelli, K. Olgaard et al., Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement, Nephrol Dial Transplant, vol.25, issue.12, pp.3823-3854, 2010.

, KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD), Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, pp.1-130, 2009.

M. Ketteler, G. A. Block, P. Evenpoel, M. Fukagawa, C. A. Herzog et al., Executive summary of the 2017 KDIGO chronic Kidney Disease-mineral and bone disorder (CKD-MBD) Guideline update: what's changed and why it matters, Kidney international, vol.92, pp.26-36, 2017.

F. Tentori, M. J. Blayney, J. M. Albert, B. W. Gillespie, P. G. Kerr et al., Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, vol.52, issue.3, pp.519-549, 2008.

C. Couchoud, B. Stengel, and P. Landais, The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrol Dial Transplant, vol.21, pp.411-418, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

D. V. Glidden and E. Vittinghoff, Modelling clustered survival data from multicenter clinical trials, Stat Med, vol.23, issue.3, pp.369-88, 2004.

E. W. Young, J. M. Albert, S. Satayathum, D. A. Goodkin, R. L. Pisoni et al., Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study, Kidney Int, vol.67, issue.3, pp.1179-87, 2005.

M. E. Roth, H. London, G. M. Jean, G. Hannedouche, T. Bouchet et al., Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. French Calcium and Phosphate Observatory, Kidney Int, vol.89, issue.3, pp.666-74, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01850355

H. W. Kim, S. H. Kim, Y. O. Kim, D. C. Jin, H. C. Song et al., Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients, Medicine (Baltimore), vol.94, issue.40, p.1694, 2015.

J. R. Lu, Y. Yi, Z. X. Xiong, X. F. Cheng, J. Hu et al., The Study of Low Calcium Dialysate on Elderly Hemodialysis Patients with Secondary Hypoparathyroidism, Blood Purif, vol.42, issue.1, pp.3-8, 2016.

S. M. Brunelli, S. Sibbel, T. P. Do, K. Cooper, and B. D. Bradbury, Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study, Am J Kidney Dis, vol.66, issue.4, pp.655-65, 2015.

D. Russo, I. Miranda, C. Ruocco, Y. Battaglia, E. Buonanno et al., The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer, Kidney Int, vol.72, issue.10, pp.1255-61, 2007.

W. Qunibi, M. Moustafa, L. R. Muenz, D. Y. He, P. D. Kessler et al., A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study, Am J Kidney Dis, vol.51, issue.6, pp.952-65, 2008.

S. C. Palmer, S. Gardner, M. Tonelli, D. Mavridis, D. W. Johnson et al., Phosphate-binding agents with CKD: a network meta-analysis of randomized trials, Am j Kidney dis, vol.68, issue.5, pp.691-702, 2016.

G. M. Chertow, G. A. Block, R. Correa-rotter, T. B. Drü-eke, J. Floege et al., Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. EVOLVE Trial Investigators, N Engl J Med, vol.367, issue.26, pp.2482-94, 2012.